摘要
Introduction: The Fracture Risk Assessment Tool (FRAX) estimates 10-year probabilities of major osteoporotic fracture (MOF) and hip fracture. Whether these two components differentially predict response to denosumab remains unclear. Objectives: To determine whether baseline FRAX-MOF and FRAX-hip probabilities show opposing associations with 1-year bone mineral density (BMD) improvement after denosumab. Methods: Patients with osteoporosis who had BMD measured at baseline and 12 months after initiating denosumab were enrolled. Clinical risk factors were obtained by structured interview, and Taiwan-specific FRAX probabilities for MOF and hip fracture were calculated. Logistic regression examined the association between each FRAX probability and BMD improvement (primary outcome). Results: Among 150 denosumab-treated patients, a higher FRAX-MOF probability was associated with a lower likelihood of BMD improvement (P = 0.011; OR 0.81; 95% CI 0.68–0.95), whereas a higher FRAX-hip probability was associated with a greater likelihood of improvement (P ' 0.001; OR 1.74; 95% CI 1.30–2.34). Conclusion: FRAX components convey differential predictive information for denosumab response: higher FRAX-hip probability predicts benefit, while higher FRAX-MOF probability predicts attenuated BMD gain. Recognizing these opposing directions may refine patient selection and expectation-setting for denosumab in osteoporosis care. Mini-Abstract: This study shows that fracture risk scores predict denosumab response differently: hip fracture risk predicts stronger bone density gains, while major osteoporotic fracture risk predicts weaker gains. Recognizing these opposing signals can improve patient selection and treatment expectations in osteoporosis management.
| 原文 | 英語 |
|---|---|
| 文章編號 | 101672 |
| 期刊 | Journal of Clinical Densitometry |
| 卷 | 29 |
| 發行號 | 2 |
| DOIs | |
| 出版品狀態 | 已出版 - 01 04 2026 |
文獻附註
Publisher Copyright:Copyright © 2026. Published by Elsevier Inc.
指紋
深入研究「Differential predictive value of FRAX Hip and major osteoporotic fracture probabilities for denosumab response」主題。共同形成了獨特的指紋。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver